Zydus Lifesciences Buyback Latest News Today

June 14, 2022 5:01:00 PM

The drug firm, earlier known as Cadila Healthcare, has fixed July 15, 2022 as the last date for the settlement of bids on stock exchanges which may even happen early, as per a regulatory filing. The ...

July 18, 2024 4:16:00 PM

Zydus Lifesciences' injectables manufacturing facility in Jarod, near Vadodara, has been classified as 'Official Action Indicated' by the USFDA following an inspection. This implies regulatory ...

April 10, 2023 3:49:00 AM

Photo: Mint Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma. The company has received the ...

June 14, 2024 11:40:00 PM

The tentative approval by the US Food and Drug Administration (USFDA) is for Azilsartan Medoxomil and Chlorthalidone tablets of strengths 40 mg/12.5 mg and 40 mg/25 mg, Zydus Lifesciences said in ...

July 17, 2024 4:01:00 PM

Zydus Lifesciences announced a licensing agreement with Takeda Pharmaceutical to market Vonoprazan, a drug for gastroesophageal reflux disease (GERD), in India. Marketed under the brand name Vault, ...

February 9, 2024 7:40:00 PM

AHMEDABAD: Homegrown pharma major, Zydus Lifesciences Limited on Friday posted ... The company�s board approved buyback of 57.9 lakh shares worth Rs 600 crore at Rs 1,005 per share via tender ...

July 12, 2024 3:30:00 AM

Zydus Lifesciences Ltd share price was up by 1.01% from the previous closing price of ?1,163.35. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

August 11, 2023 10:27:00 AM

New Delhi, Zydus Lifesciences Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 1,086.9 crore for the first quarter ended June 30, 2023 driven by strong sales growth from ...

July 16, 2024 3:30:00 AM

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...